GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Other Financing

ALMS (Alumis) Other Financing : $-1.25 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alumis Other Financing?

Alumis's Other Financing for the three months ended in Sep. 2024 was $0.00 Mil.

Alumis's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.25 Mil.


Alumis Other Financing Historical Data

The historical data trend for Alumis's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis Other Financing Chart

Alumis Annual Data
Trend Dec22 Dec23
Other Financing
1.73 -0.10

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial - - 0.03 -1.28 -

Alumis Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alumis Other Financing Related Terms

Thank you for viewing the detailed overview of Alumis's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Alumis Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.